An Observational Study to Describe the Long-term Safety and Effectiveness of Namuscla in the Symptomatic Management of Myotonia in Adult Patients with Non-dystrophic Myotonic DisordersFirst published 10/11/2020 Last updated 14/03/2024 EU PAS number: EUPAS37943StudyOngoing